Multiple Lawsuits Against GLP-1 Manufacturers Claim Drugs Carry Risk Of Sudden Vision Loss
Thousands of personal-injury complaints say the diabetes and weight-loss drugs were not labeled for sudden, often permanent vision loss, lawyers said.
4 Articles
4 Articles
Ozempic, Mounjaro face lawsuits in the US over vision loss. What's the risk?
US lawsuits have put a spotlight on claims that GLP-1 drugs may be linked to the rare eye condition NAION. Doctors say the evidence remains mixed, with no reported cases in India so far and the risk still under investigation.
Can Ozempic Cause Blindness? Dozens Sue Over Alleged Link to Rare 'Eye Stroke' Condition
Dozens of US patients are pursuing lawsuits alleging GLP-1 drugs caused NAION, while UK and European regulators have classified the condition as a very rare possible side effect of semaglutide.
Multiple Lawsuits Against GLP-1 Manufacturers Claim Drugs Carry Risk Of Sudden Vision Loss
Several lawsuits filed against the manufacturers of the GLP-1 drugs Ozempic, Wegovy, and Mounjaro claim that some patients experienced sudden vision loss after taking the medications. The complaints were filed against Eli Lilly and Novo Nordisk.RELATED: Aht Aht! Boston Richey Reacts After Fans Question His Weight Loss Following New Video Lawsuits Claim GLP-1 Drugs Carry Risk [...]
Hundreds of lawsuits allege GLP-1s like Ozempic, Wegovy, Mounjaro caused vision loss
PHOENIX (AZFamily/Gray News) — Hundreds of lawsuits have been filed against major GLP-1 makers Eli Lilly and Novo Nordisk with patients accusing the popular weight-loss drugs of causing permanent eye damage and vision loss. According to USA Today, multiple lawsuits filed within the last year focus…
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
